<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="editorial" dtd-version="3.0" xml:lang="EN">
 <front>
  <journal-meta><journal-id journal-id-type="nlm-ta">PLoS Negl Trop Dis</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosntds</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS Neglected Tropical Diseases</journal-title></journal-title-group><issn pub-type="epub">1935-2735</issn><publisher>
    <publisher-name>Public Library of Science</publisher-name>
    <publisher-loc>San Francisco, USA</publisher-loc>
   </publisher></journal-meta>
  <article-meta><article-id pub-id-type="publisher-id">09-PNTD-ED-0196R2</article-id><article-id pub-id-type="doi">10.1371/journal.pntd.0000470</article-id><article-categories>
    <subj-group subj-group-type="heading">
     <subject>Editorial</subject>
    </subj-group>
    <subj-group subj-group-type="Discipline">
     <subject>Infectious Diseases/Neglected Tropical Diseases</subject>
    </subj-group>
   </article-categories><title-group><article-title>The Unfinished Public Health Agenda of Chagas Disease in the Era of
     Globalization</article-title></title-group><contrib-group>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>Franco-Paredes</surname>
      <given-names>Carlos</given-names>
     </name>
     <xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
     <xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
     <xref ref-type="corresp" rid="cor1"><sup>*</sup></xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>Bottazzi</surname>
      <given-names>Maria Elena</given-names>
     </name>
     <xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
     <xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>Hotez</surname>
      <given-names>Peter J.</given-names>
     </name>
     <xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
     <xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
    </contrib>
   </contrib-group><aff id="aff1"><label>1</label><addr-line>Hospital Infantil de México, Federico
     Gómez, México, D.F., México</addr-line>
   </aff><aff id="aff2"><label>2</label><addr-line>Department of Medicine, Emory University, Atlanta,
     Georgia, United States of America</addr-line>
   </aff><aff id="aff3"><label>3</label><addr-line>Department of Microbiology, Immunology, and Tropical
     Medicine, The George Washington University, Washington, D.C., United States of
     America</addr-line>
   </aff><aff id="aff4"><label>4</label><addr-line>Sabin Vaccine Institute, Washington, D.C., United
     States of America</addr-line>
   </aff><author-notes>
    <corresp id="cor1">* E-mail: <email xlink:type="simple">cfranco@sph.emory.edu</email></corresp>
   <fn fn-type="conflict">
    <p>PJH is a co-founder of the Global Network for Neglected Tropical Diseases and President of
     the Sabin Vaccine Institute. PJH is also Editor-in-Chief of <italic>PLoS Neglected Tropical
      Diseases</italic>.</p>
   </fn></author-notes><pub-date pub-type="collection">
    <month>7</month>
    <year>2009</year>
   </pub-date><pub-date pub-type="epub">
    <day>7</day>
    <month>7</month>
    <year>2009</year>
   </pub-date><volume>3</volume><issue>7</issue><elocation-id>e470</elocation-id><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2009</copyright-year><copyright-holder>Franco-Paredes et al</copyright-holder><license><license-p>This is an open-access article distributed under the
    terms of the Creative Commons Attribution License, which permits unrestricted use, distribution,
    and reproduction in any medium, provided the original author and source are
    credited.</license-p></license></permissions><related-article ext-link-type="uri" id="RA" issue="7" page="e484" related-article-type="companion" vol="3" xlink:href="info:doi/10.1371/journal.pntd.0000484" xlink:title="Policy Platform" xlink:type="simple"><article-title>New, Improved Treatments for Chagas Disease: From the R&amp;D Pipeline to the
     Patients</article-title></related-article><related-article ext-link-type="uri" id="RA1" issue="7" page="e488" related-article-type="companion" vol="3" xlink:href="info:doi/10.1371/journal.pntd.0000488" xlink:title="Research Article" xlink:type="simple"><article-title>Feasibility, Drug Safety, and Effectiveness of Etiological Treatment Programs
     for Chagas Disease in Honduras, Guatemala, and Bolivia: 10-Year Experience of Médecins
     Sans Frontières</article-title></related-article><funding-group><funding-statement>Carlos Franco-Paredes is supported by a grant of the Healthcare Georgia Foundation and the
     Emory Global Health Institute of Emory University. The funders had no role in study design,
     data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts>
    <page-count count="4"/>
   </counts></article-meta>
 </front>
 <body>
  <sec id="s1">
   <title/>
   <disp-quote>
    <p><bold><italic>“It takes all the running you can do, to keep in the same place. If you
       want to get somewhere else, you must run at least twice as fast as
      that!”</italic></bold></p>
    <p><bold>Lewis Carroll's </bold><bold><italic>Through the
      Looking-Glass</italic></bold><bold> </bold><xref ref-type="bibr" rid="pntd.0000470-Carroll1">[<bold>1</bold>]</xref></p>
   </disp-quote>
   <p>Many neglected tropical diseases (NTDs) began millions of years ago as enzoonotic diseases of
    wild animals that subsequently infected humans, leading in many cases to anthropozoonoses <xref ref-type="bibr" rid="pntd.0000470-RodriguesCoura1">[2]</xref>. Because of their
    impoverished circumstances, most humans infected with NTD agents have few choices but to face
    daily the intense selective pressures associated with high levels of exposure and transmission
    that often flourish in these impoverished settings <xref ref-type="bibr" rid="pntd.0000470-FrancoParedes1">[3]</xref>. In this dynamic and relentless
    evolutionary battle, animal reservoirs, vectors, microbes causing NTDs, and humans are
    constantly adapting through what it is known as the “Red Queen Effect” from Lewis
    Carroll's Red Queen character <xref ref-type="bibr" rid="pntd.0000470-Gee1">[4]</xref>,<xref ref-type="bibr" rid="pntd.0000470-Decaestecker1">[5]</xref>. Typically, the battlegrounds of these molecular and ecological clashes
    are located in the poorest regions of developing countries where they mostly affect the
    world's most vulnerable populations <xref ref-type="bibr" rid="pntd.0000470-FrancoParedes1">[3]</xref>.</p>
   <p>In Latin America, Chagas disease (CD), caused by infection with <italic>Trypanosoma
     cruzi</italic>, is a prime example of this co-evolutionary process in which parasites and
    mammalian reservoirs (including humans) are engaged in a dynamic race of ecological adaptation
    and counter-adaptation <xref ref-type="bibr" rid="pntd.0000470-Hotez1">[6]</xref>. In
    the search for improved sources of income, agriculture, livestock rearing, and other
    socioeconomic activities, human populations began migrating into the natural wild habitats where
     <italic>T. cruzi</italic> infection was enzootic <xref ref-type="bibr" rid="pntd.0000470-RodriguesCoura1">[2]</xref>. Ultimately, poverty, poor housing and
    sub-standard living conditions, deforestation, and other ecological factors promoted an
    adaptation of triatomine vectors to both humans and domestic animals, with increased
    efficiencies of the wild, domestic, and peridomestic cycles of <italic>T. cruzi</italic>
    transmission (<xref ref-type="fig" rid="pntd-0000470-g001">Figure 1</xref>) <xref ref-type="bibr" rid="pntd.0000470-RodriguesCoura1">[2]</xref>, <xref ref-type="bibr" rid="pntd.0000470-Miles1">[7]</xref>–<xref ref-type="bibr" rid="pntd.0000470-Yamagata1">[8]</xref>. Once humans became infected and acted as a
    reservoir for the infection, other forms of transmission also evolved through blood transfusion,
    congenital transmission, and organ transplantation. In some settings, oral transmission through
    contaminated food is now considered an important mode of transmission <xref ref-type="bibr" rid="pntd.0000470-FrancoParedes1">[3]</xref>,<xref ref-type="bibr" rid="pntd.0000470-Yamagata1">[8]</xref>.</p>
   <fig id="pntd-0000470-g001" position="float">
    <object-id pub-id-type="doi">10.1371/journal.pntd.0000470.g001</object-id>
    <label>Figure 1</label>
    <caption>
     <title>The cycle of transmission of <italic>Trypanosoma cruzi</italic>, the causative agent of
      Chagas disease to humans.</title>
     <p>From <xref ref-type="bibr" rid="pntd.0000470-FrancoParedes1">[3]</xref>.</p>
    </caption>
    <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pntd.0000470.g001" xlink:type="simple"/>
   </fig>
   <p>We are about to celebrate the 100th anniversary of the discovery of <italic>T. cruzi</italic>
    and its link to CD. The cycle of transmission (vector, reservoir, and infectious agent) and the
    clinical manifestations of the disease were elegantly described by Carlos Chagas
    (1879–1934) during the first decade of the 20th century. Oswaldo Cruz, his mentor, had set
    the stage for these achievements by creating a research institution bearing his name in Brazil
    (Instituto Oswaldo Cruz – FIOCRUZ) <xref ref-type="bibr" rid="pntd.0000470-Miles1">[7]</xref>, <xref ref-type="bibr" rid="pntd.0000470-Morel1">[9]</xref>–<xref ref-type="bibr" rid="pntd.0000470-Bastein1">[10]</xref>. For his multiple achievements, Carlos Chagas received several awards
    and international distinctions and became the Director of the Institute in 1917 (after Oswaldo
    Cruz's death), holding this title until his own death in 1934. It was Salvador Mazza in
    Argentina who brought again Chagas's achievements into the international scope by
    identifying cases of CD in the Argentine Chaco region <xref ref-type="bibr" rid="pntd.0000470-Morel1">[9]</xref>. In subsequent years, a few dedicated clinicians
    in Latin America expanded the initial clinical descriptions of the disease made by Carlos
    Chagas. During this period, the French parasitologist Emile Brumpt is often credited with
    developing important xenodiagnostic techniques <xref ref-type="bibr" rid="pntd.0000470-Bastein1">[10]</xref>.</p>
   <p>Due to these landmark discoveries, it is now recognized that the natural history of CD has
    three clinical stages <xref ref-type="bibr" rid="pntd.0000470-RodriguesCoura1">[2]</xref>,<xref ref-type="bibr" rid="pntd.0000470-FrancoParedes1">[3]</xref>. An initial acute stage representing the entry of the parasite and
    invasion of the bloodstream in which most patients are asymptomatic is followed by an
    indeterminate stage that is defined by the absence of symptoms and clinical findings in patients
    with a positive serology for <italic>T. cruzi</italic>. The indeterminate stage (also called
    early chronic) is followed by chronic complications in approximately 20%–30%
    of patients many years after the initial infection. Serious cardiac (e.g., cardiomyopathy) and
    gastrointestinal (e.g., megaesophagus and megacolon) morbidities are the most frequent
    manifestations of chronic CD and the main cause of disability and death <xref ref-type="bibr" rid="pntd.0000470-RodriguesCoura1">[2]</xref>.</p>
   <p>During the early 1980s, the prevalence of CD was first reliably estimated and the full social
    and economic implications of this condition were revealed. It was determined that there were 18
    million cases in 21 endemic countries with 100 million people at risk of infection <xref ref-type="bibr" rid="pntd.0000470-Morel1">[9]</xref>. In 1993, CD ranked as the most
    important tropical disease in Latin America in terms of burden of disease <xref ref-type="bibr" rid="pntd.0000470-Morel1">[9]</xref>. Subsequently, through political commitment and
    effective public health interventions, some progress was achieved in reducing the incidence and
    prevalence of CD, particularly in the southernmost countries of Latin America. The major
    approaches to control CD have included improved case management and vector control programs,
    together with housing improvement through regional programs and blood bank screening <xref ref-type="bibr" rid="pntd.0000470-RodriguesCoura1">[2]</xref>, <xref ref-type="bibr" rid="pntd.0000470-Hotez1">[6]</xref>, <xref ref-type="bibr" rid="pntd.0000470-Miles1">[7]</xref>–<xref ref-type="bibr" rid="pntd.0000470-Morel1">[9]</xref>. To date, the major regional initiatives combining some of these
    interventions have included the Southern Cone Initiative (INCOSUR) created in 1991, followed by
    the Andean Initiative in 1997 (ACI-IPA), and the Central America and Mexico Initiative
    (IPCA-MEXICO) and Amazon Initiative (AMCHA) in 2004. As a result of these programs and according
    to the most recent estimates, the number of people currently infected with CD has been reduced
    to approximately 7.6 million, with 75 million people still living at risk of infection <xref ref-type="bibr" rid="pntd.0000470-Guhl1">[11]</xref>.</p>
   <p>In spite of these substantial achievements, many challenges remain ahead for the control and
    ultimately the elimination of CD. Together with the intestinal helminth infections, CD is
    responsible for the highest estimated disease burden due to infectious diseases in Latin America
     <xref ref-type="bibr" rid="pntd.0000470-Hotez1">[6]</xref>. In addition, the huge
    impact of CD on worker productivity and maternal child health continues to contribute to
    underdevelopment <xref ref-type="bibr" rid="pntd.0000470-FrancoParedes1">[3]</xref>,<xref ref-type="bibr" rid="pntd.0000470-Hotez1">[6]</xref>.
    Some of the successes in the control of the disease are in jeopardy. For instance, in the
    Southern Cone, where domestic transmission has been nearly eliminated through vector control of
     <italic>Triatoma infestans</italic>, there are concerns that the vacant niches will be
    eventually occupied by other triatomine vectors <xref ref-type="bibr" rid="pntd.0000470-Hotez1">[6]</xref>,<xref ref-type="bibr" rid="pntd.0000470-Yamagata1">[8]</xref>.
    In other parts of Latin America, poor governance and politically motivated human rights
    violations have facilitated the emergence and geographic spread of CD <xref ref-type="bibr" rid="pntd.0000470-Beyrer1">[12]</xref>. There is even strong evidence for
    autochthonous transmission within the borders of the United States, especially in the southern
    states <xref ref-type="bibr" rid="pntd.0000470-Bern1">[13]</xref>. Additionally, due
    to regional and global migration caused by economic hardship, the geographic reach of CD has
    expanded from rural to urban areas in endemic countries as well as in non-endemic countries, a
    phenomenon sometimes referred to as the globalization of CD (<xref ref-type="fig" rid="pntd-0000470-g002">Figure 2</xref>) <xref ref-type="bibr" rid="pntd.0000470-Schmunis1">[14]</xref>.</p>
   <fig id="pntd-0000470-g002" position="float">
    <object-id pub-id-type="doi">10.1371/journal.pntd.0000470.g002</object-id>
    <label>Figure 2</label>
    <caption>
     <title>Globalization of Chagas disease from endemic to non-endemic settings.</title>
     <p>Reprinted with permission from <italic>Memórias do Instituto Oswaldo Cruz</italic>
      <xref ref-type="bibr" rid="pntd.0000470-Schmunis1">[14]</xref>.</p>
    </caption>
    <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pntd.0000470.g002" xlink:type="simple"/>
   </fig>
   <p>Current prevention strategies are not enough to control the burden of disease associated with
    CD. The diagnosis and treatment for every affected individual with CD are moral imperatives and
    represent a human rights priority <xref ref-type="bibr" rid="pntd.0000470-Beyrer1">[12]</xref>. Health care access for diagnosis and treatment is limited in
    impoverished areas in highly endemic settings <xref ref-type="bibr" rid="pntd.0000470-FrancoParedes1">[3]</xref>. The major antiparasitic drugs used are
    expensive or toxic, sometimes unavailable, and are not sufficiently effective to treat the
    chronic forms of the disease <xref ref-type="bibr" rid="pntd.0000470-Hotez1">[6]</xref>,<xref ref-type="bibr" rid="pntd.0000470-Yamagata1">[8]</xref>.
    In this and an upcoming issue of <italic>PLoS Neglected Tropical Diseases</italic>, a series of
    articles coordinated by Médicins Sans Frontiéres (MSF) and Drugs for Neglected
    Disease Initiative (DNDi) address some of the challenges and ongoing intervention strategies led
    by these two organizations to ameliorate the medical impact of CD in highly affected areas <xref ref-type="bibr" rid="pntd.0000470-Yun1">[15]</xref>,<xref ref-type="bibr" rid="pntd.0000470-Ribeiro1">[16]</xref>.</p>
   <p>In the first report of the series, MSF workers in the field demonstrate from an operational
    perspective the feasibility of implementing CD diagnosis and treatment protocols in highly
    affected populations in Honduras, Guatemala, and Bolivia <xref ref-type="bibr" rid="pntd.0000470-Yun1">[15]</xref>. Through their important contributions in the
    diagnosis and treatment of CD, MSF has proven the importance of establishing case management
    protocols that include information, education, and communication at the community and family
    level, as well as protocols for health staff training with regard to screening, diagnosis, and
    treatment of CD. This study also confirms the need for better drugs with improved safety
    profiles, the urgent need for the development of formulations for pediatric cases, and the need
    for better serological or molecular tests of cure within case management protocols <xref ref-type="bibr" rid="pntd.0000470-Yun1">[15]</xref>. In another article in the
    series, Riberio et al. present the current and future state of CD drug development by describing
    current research and development funding, products in the development pipeline, and products
    undergoing clinical evaluation <xref ref-type="bibr" rid="pntd.0000470-Ribeiro1">[16]</xref>.</p>
   <p>In the coming decade, we anticipate multiple challenges to control or eliminate the medical
    and public health impact of CD. They include the following:</p>
   <list list-type="bullet">
    <list-item>
     <p>scaling of integrated control programs throughout all affected countries by blood bank
      screening, residual insecticide treatment of vector-infested homes, health promotion and
      education, and community surveillance of house re-infestation in endemic settings <xref ref-type="bibr" rid="pntd.0000470-Hotez1">[6]</xref>;</p>
    </list-item>
    <list-item>
     <p>improving access to high-quality health care for diagnosis and treatment of CD and its
      cardiac, gastrointestinal, and neurological complications in endemic settings <xref ref-type="bibr" rid="pntd.0000470-Yun1">[15]</xref>;</p>
    </list-item>
    <list-item>
     <p>expanding screening, diagnosis, and treatment protocols of CD in non-endemic settings
      receiving large numbers of migrants from areas of endemicity in Latin America <xref ref-type="bibr" rid="pntd.0000470-Bern1">[13]</xref>,<xref ref-type="bibr" rid="pntd.0000470-Schmunis1">[14]</xref>;</p>
    </list-item>
    <list-item>
     <p>expanding screening and treatment to prevent congenital CD transmission in endemic settings
       <xref ref-type="bibr" rid="pntd.0000470-Hotez1">[6]</xref>;</p>
    </list-item>
    <list-item>
     <p>developing and testing more efficacious and safer drugs for the acute, indeterminate, and
      chronic forms of the disease <xref ref-type="bibr" rid="pntd.0000470-Ribeiro1">[16]</xref>; and</p>
    </list-item>
    <list-item>
     <p>further defining the epidemiologic and clinical manifestations of CD co-infection or
      reactivation among patients with HIV/AIDS and other immunocompromised populations in endemic
      and non-endemic settings <xref ref-type="bibr" rid="pntd.0000470-DiazGranados1">[17]</xref>.</p>
    </list-item>
   </list>
   <p>In order to address these challenges, and in support of the existing MSF and DNDi initiatives,
    the Global Network for Neglected Tropical Diseases of the Sabin Vaccine Institute is working in
    collaboration with the Inter-American Development Bank and the Pan American Health Organization
    to support large-scale programs for the control of CD and other NTDs in the Latin American
    region. Simultaneously, several product development partnerships, including DNDi and the Sandler
    Center at the University of California San Francisco, as well as a new NTD research and
    development initiative of the Brazilian Ministry of Health, are working to develop new and
    improved control tools for CD. Once again, FIOCRUZ will be at the forefront of many of these new
    endeavors.</p>
   <p>In summary, there are ongoing social and biological evolutionary races surrounding CD
    transmission and control on a global scale. We <bold><italic>must run at least twice as
      fast</italic></bold> to increase our efforts to control this poverty-promoting disease. By
    controlling CD and other NTDs in Latin America, as demonstrated by the programs and strategies
    of MSF and DNDi, the most vulnerable populations in this region may be in a better position to
    achieve the Millennium Development Goals.</p>
  </sec>
 </body>
 <back>
  <ref-list>
   <title>References</title>
   <ref id="pntd.0000470-Carroll1">
    <label>1</label>
    <element-citation publication-type="other" xlink:type="simple">
     <person-group person-group-type="author">
      <name name-style="western">
       <surname>Carroll</surname>
       <given-names>L</given-names>
      </name>
     </person-group>
     <year>1974</year>
     <article-title>The annotated Alice: Alice's Adventures in Wonderland and Through the
      Looking-Glass.</article-title>
     <person-group person-group-type="editor">
      <name name-style="western">
       <surname>Gardner</surname>
       <given-names>M</given-names>
      </name>
     </person-group>
     <publisher-loc>New York</publisher-loc>
     <publisher-name>New American Library</publisher-name>
    </element-citation>
   </ref>
   <ref id="pntd.0000470-RodriguesCoura1">
    <label>2</label>
    <element-citation publication-type="journal" xlink:type="simple">
     <person-group person-group-type="author">
      <name name-style="western">
       <surname>Rodrigues Coura</surname>
       <given-names>J</given-names>
      </name>
     </person-group>
     <year>2007</year>
     <article-title>Chagas disease: what is known and what is needed—a background
      article.</article-title>
     <source>Mem Inst Oswaldo Cruz</source>
     <volume>102</volume>
     <supplement>(Suppl 1)</supplement>
     <fpage>113</fpage>
     <lpage>122</lpage>
    </element-citation>
   </ref>
   <ref id="pntd.0000470-FrancoParedes1">
    <label>3</label>
    <element-citation publication-type="journal" xlink:type="simple">
     <person-group person-group-type="author">
      <name name-style="western">
       <surname>Franco-Paredes</surname>
       <given-names>C</given-names>
      </name>
      <name name-style="western">
       <surname>Von</surname>
       <given-names>A</given-names>
      </name>
      <name name-style="western">
       <surname>Hidron</surname>
       <given-names>A</given-names>
      </name>
      <name name-style="western">
       <surname>Rodríguez-Morales</surname>
       <given-names>AJ</given-names>
      </name>
      <name name-style="western">
       <surname>Tellez</surname>
       <given-names>I</given-names>
      </name>
      <etal/>
     </person-group>
     <year>2007</year>
     <article-title>Chagas disease: an impediment in achieving the Millennium Development Goals in
      Latin America.</article-title>
     <source>BMC Int Health Hum Rights</source>
     <volume>7</volume>
     <fpage>7</fpage>
     <comment>Available: <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1472-698X/7/7" xlink:type="simple">http://www.biomedcentral.com/1472-698X/7/7</ext-link>. Accessed 9 June 2009</comment>
    </element-citation>
   </ref>
   <ref id="pntd.0000470-Gee1">
    <label>4</label>
    <element-citation publication-type="journal" xlink:type="simple">
     <person-group person-group-type="author">
      <name name-style="western">
       <surname>Gee</surname>
       <given-names>H</given-names>
      </name>
      <name name-style="western">
       <surname>Howlett</surname>
       <given-names>R</given-names>
      </name>
      <name name-style="western">
       <surname>Campbell</surname>
       <given-names>P</given-names>
      </name>
     </person-group>
     <year>2009</year>
     <article-title>15 evolutionary gems.</article-title>
     <source>Nature</source>
     <volume>457</volume>
     <fpage>8</fpage>
     <comment>Available: <ext-link ext-link-type="uri" xlink:href="http://www.nature.com/nature/newspdf/evolutiongems.pdf" xlink:type="simple">http://www.nature.com/nature/newspdf/evolutiongems.pdf</ext-link>. Accessed 9 June
      2009</comment>
    </element-citation>
   </ref>
   <ref id="pntd.0000470-Decaestecker1">
    <label>5</label>
    <element-citation publication-type="journal" xlink:type="simple">
     <person-group person-group-type="author">
      <name name-style="western">
       <surname>Decaestecker</surname>
       <given-names>E</given-names>
      </name>
      <name name-style="western">
       <surname>Gaba</surname>
       <given-names>S</given-names>
      </name>
      <name name-style="western">
       <surname>Raeymaekers</surname>
       <given-names>JA</given-names>
      </name>
      <name name-style="western">
       <surname>Stoks</surname>
       <given-names>R</given-names>
      </name>
      <name name-style="western">
       <surname>Van Kerckhoven</surname>
      </name>
      <etal/>
     </person-group>
     <year>2007</year>
     <article-title>Host-parasite ‘Red Queen’ dynamics archived in pond
      sediment.</article-title>
     <source>Nature</source>
     <volume>450</volume>
     <fpage>870</fpage>
     <lpage>875</lpage>
    </element-citation>
   </ref>
   <ref id="pntd.0000470-Hotez1">
    <label>6</label>
    <element-citation publication-type="journal" xlink:type="simple">
     <person-group person-group-type="author">
      <name name-style="western">
       <surname>Hotez</surname>
       <given-names>PJ</given-names>
      </name>
      <name name-style="western">
       <surname>Bottazzi</surname>
       <given-names>ME</given-names>
      </name>
      <name name-style="western">
       <surname>Franco-Paredes</surname>
       <given-names>C</given-names>
      </name>
      <name name-style="western">
       <surname>Ault</surname>
       <given-names>SK</given-names>
      </name>
      <name name-style="western">
       <surname>Roses-Periago</surname>
       <given-names>M</given-names>
      </name>
     </person-group>
     <year>2008</year>
     <article-title>The neglected tropical diseases of Latin America and the Caribbean: estimated
      disease burden and distribution and a roadmap for control and elimination.</article-title>
     <source>PLoS Negl Trop Dis</source>
     <volume>2</volume>
     <fpage>e300</fpage>
     <comment>doi:10.1371/journal.pntd.0000300</comment>
    </element-citation>
   </ref>
   <ref id="pntd.0000470-Miles1">
    <label>7</label>
    <element-citation publication-type="journal" xlink:type="simple">
     <person-group person-group-type="author">
      <name name-style="western">
       <surname>Miles</surname>
       <given-names>MA</given-names>
      </name>
     </person-group>
     <year>2004</year>
     <article-title>The discovery of Chagas disease: progress and prejudice.</article-title>
     <source>Infect Dis Clin North Am</source>
     <volume>18</volume>
     <fpage>247</fpage>
     <lpage>260</lpage>
    </element-citation>
   </ref>
   <ref id="pntd.0000470-Yamagata1">
    <label>8</label>
    <element-citation publication-type="journal" xlink:type="simple">
     <person-group person-group-type="author">
      <name name-style="western">
       <surname>Yamagata</surname>
       <given-names>Y</given-names>
      </name>
      <name name-style="western">
       <surname>Nakagawa</surname>
       <given-names>J</given-names>
      </name>
     </person-group>
     <year>2006</year>
     <article-title>Control of Chagas disease.</article-title>
     <source>Adv Parasitol</source>
     <volume>61</volume>
     <fpage>129</fpage>
     <lpage>167</lpage>
    </element-citation>
   </ref>
   <ref id="pntd.0000470-Morel1">
    <label>9</label>
    <element-citation publication-type="journal" xlink:type="simple">
     <person-group person-group-type="author">
      <name name-style="western">
       <surname>Morel</surname>
       <given-names>CM</given-names>
      </name>
     </person-group>
     <year>1999</year>
     <article-title>Chagas disease, from discovery to control - and beyond: history, myths and
      lessons to take home.</article-title>
     <source>Mem Inst Oswaldo Cruz</source>
     <volume>94</volume>
     <supplement>(Suppl 1)</supplement>
     <fpage>3</fpage>
     <lpage>16</lpage>
    </element-citation>
   </ref>
   <ref id="pntd.0000470-Bastein1">
    <label>10</label>
    <element-citation publication-type="other" xlink:type="simple">
     <person-group person-group-type="author">
      <name name-style="western">
       <surname>Bastein</surname>
       <given-names>JW</given-names>
      </name>
     </person-group>
     <year>1998</year>
     <source>The kiss of death: Chagas' disease in the Americas</source>
     <publisher-loc>Salt Lake City</publisher-loc>
     <publisher-name>University of Utah Press</publisher-name>
     <fpage>301</fpage>
    </element-citation>
   </ref>
   <ref id="pntd.0000470-Guhl1">
    <label>11</label>
    <element-citation publication-type="journal" xlink:type="simple">
     <person-group person-group-type="author">
      <name name-style="western">
       <surname>Guhl</surname>
       <given-names>F</given-names>
      </name>
     </person-group>
     <year>2007</year>
     <article-title>Chagas disease in Andean countries.</article-title>
     <source>Mem Inst Oswaldo Cruz</source>
     <volume>102</volume>
     <supplement>(Suppl 1)</supplement>
     <fpage>29</fpage>
     <lpage>38</lpage>
    </element-citation>
   </ref>
   <ref id="pntd.0000470-Beyrer1">
    <label>12</label>
    <element-citation publication-type="journal" xlink:type="simple">
     <person-group person-group-type="author">
      <name name-style="western">
       <surname>Beyrer</surname>
       <given-names>C</given-names>
      </name>
      <name name-style="western">
       <surname>Villar</surname>
       <given-names>JC</given-names>
      </name>
      <name name-style="western">
       <surname>Suwanvanichkij</surname>
       <given-names>V</given-names>
      </name>
      <name name-style="western">
       <surname>Singh</surname>
       <given-names>S</given-names>
      </name>
      <name name-style="western">
       <surname>Baral</surname>
       <given-names>SD</given-names>
      </name>
      <etal/>
     </person-group>
     <year>2007</year>
     <article-title>Neglected diseases, civil conflicts, and the right to health.</article-title>
     <source>Lancet</source>
     <volume>370</volume>
     <fpage>619</fpage>
     <lpage>627</lpage>
    </element-citation>
   </ref>
   <ref id="pntd.0000470-Bern1">
    <label>13</label>
    <element-citation publication-type="journal" xlink:type="simple">
     <person-group person-group-type="author">
      <name name-style="western">
       <surname>Bern</surname>
       <given-names>C</given-names>
      </name>
      <name name-style="western">
       <surname>Montgomery</surname>
       <given-names>SP</given-names>
      </name>
      <name name-style="western">
       <surname>Herwaldt</surname>
       <given-names>BL</given-names>
      </name>
      <name name-style="western">
       <surname>Rassi</surname>
       <given-names>A</given-names>
       <suffix>Jr</suffix>
      </name>
      <name name-style="western">
       <surname>Marin-Neto</surname>
       <given-names>JA</given-names>
      </name>
      <etal/>
     </person-group>
     <year>2007</year>
     <article-title>Evaluation and treatment of Chagas disease in the United States: a systematic
      review.</article-title>
     <source>JAMA</source>
     <volume>298</volume>
     <fpage>2171</fpage>
     <lpage>2181</lpage>
    </element-citation>
   </ref>
   <ref id="pntd.0000470-Schmunis1">
    <label>14</label>
    <element-citation publication-type="journal" xlink:type="simple">
     <person-group person-group-type="author">
      <name name-style="western">
       <surname>Schmunis</surname>
       <given-names>GA</given-names>
      </name>
     </person-group>
     <year>2007</year>
     <article-title>Epidemiology of Chagas disease in non-endemic countries: the role of
      international migration.</article-title>
     <source>Mem Inst Oswaldo Cruz</source>
     <volume>102</volume>
     <supplement>(Suppl 1)</supplement>
     <fpage>75</fpage>
     <lpage>85</lpage>
    </element-citation>
   </ref>
   <ref id="pntd.0000470-Yun1">
    <label>15</label>
    <element-citation publication-type="journal" xlink:type="simple">
     <person-group person-group-type="author">
      <name name-style="western">
       <surname>Yun</surname>
       <given-names>O</given-names>
      </name>
      <name name-style="western">
       <surname>Lima</surname>
       <given-names>MA</given-names>
      </name>
      <name name-style="western">
       <surname>Ellman</surname>
       <given-names>T</given-names>
      </name>
      <name name-style="western">
       <surname>Chambi</surname>
       <given-names>W</given-names>
      </name>
      <name name-style="western">
       <surname>Castillo</surname>
       <given-names>S</given-names>
      </name>
      <etal/>
     </person-group>
     <year>2009</year>
     <article-title>Feasibility, drug safety, and effectiveness of etiological treatment programs
      for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of Médicins
      Sans Frontiéres.</article-title>
     <source>PLoS Negl Trop Dis</source>
     <comment>In press</comment>
    </element-citation>
   </ref>
   <ref id="pntd.0000470-Ribeiro1">
    <label>16</label>
    <element-citation publication-type="journal" xlink:type="simple">
     <person-group person-group-type="author">
      <name name-style="western">
       <surname>Ribeiro</surname>
       <given-names>I</given-names>
      </name>
      <name name-style="western">
       <surname>Sevcsik</surname>
       <given-names>AM</given-names>
      </name>
      <name name-style="western">
       <surname>Alves</surname>
       <given-names>F</given-names>
      </name>
      <name name-style="western">
       <surname>Diap</surname>
       <given-names>G</given-names>
      </name>
      <name name-style="western">
       <surname>Don</surname>
       <given-names>R</given-names>
      </name>
      <etal/>
     </person-group>
     <year>2009</year>
     <article-title>New, improved treatments of Chagas disease: from the R&amp;D pipeline to
      patients.</article-title>
     <source>PLoS Negl Trop Dis</source>
     <comment>In press</comment>
    </element-citation>
   </ref>
   <ref id="pntd.0000470-DiazGranados1">
    <label>17</label>
    <element-citation publication-type="journal" xlink:type="simple">
     <person-group person-group-type="author">
      <name name-style="western">
       <surname>DiazGranados</surname>
       <given-names>C</given-names>
      </name>
      <name name-style="western">
       <surname>Saavedra-Trujillo</surname>
       <given-names>CH</given-names>
      </name>
      <name name-style="western">
       <surname>Mantilla</surname>
       <given-names>M</given-names>
      </name>
      <name name-style="western">
       <surname>Valderrama</surname>
       <given-names>SL</given-names>
      </name>
      <name name-style="western">
       <surname>Alquichire</surname>
       <given-names>C</given-names>
      </name>
      <etal/>
     </person-group>
     <year>2009</year>
     <article-title>Chagasic encephalitis in HIV patients: common presentation of an evolving
      epidemiological and clinical association.</article-title>
     <source>Lancet Infect Dis</source>
     <volume>9</volume>
     <fpage>324</fpage>
     <lpage>330</lpage>
    </element-citation>
   </ref>
  </ref-list>
  
 </back>
</article>